Access cutting-edge neuroblastoma treatment through this clinical trial at a research site in Tucson. Study-provided care at no cost to qualified participants.
Access neuroblastoma specialists in Tucson at no cost
This study follows strict safety protocols and ethical guidelines
All study-related neuroblastoma treatment provided free
This phase III trial tests how well the addition of dinutuximab to Induction chemotherapy along with standard of care surgical resection of the primary tumor, radiation, stem cell transplantation, and immunotherapy works for treating children with newly diagnosed high-risk neuroblastoma. Dinutuximab is a monoclonal antibody that binds to a molecule called GD2, which is found on the surface of neuroblastoma cells, but is not present on many healthy or normal cells in the body. When dinutuximab bi
Sponsor: National Cancer Institute (NCI)
Check if you qualify for this neuroblastoma clinical trial in Tucson, AZ
If you're searching for neuroblastoma treatment options in Tucson, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Tucson research site is actively enrolling participants for this clinical trial. You'll receive care from experienced neuroblastoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.